0 false false false false false false false true false false true false false false false false false No description of principal activity 2023-02-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13123843 2023-02-01 2024-01-31 13123843 2024-01-31 13123843 2023-01-31 13123843 2022-02-01 2023-01-31 13123843 2023-01-31 13123843 2022-01-31 13123843 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 13123843 bus:OrdinaryShareClass2 2023-02-01 2024-01-31 13123843 bus:Director1 2023-02-01 2024-01-31 13123843 core:WithinOneYear 2024-01-31 13123843 core:WithinOneYear 2023-01-31 13123843 core:ShareCapital 2024-01-31 13123843 core:ShareCapital 2023-01-31 13123843 core:RetainedEarningsAccumulatedLosses 2024-01-31 13123843 core:RetainedEarningsAccumulatedLosses 2023-01-31 13123843 bus:SmallEntities 2023-02-01 2024-01-31 13123843 bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 13123843 bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 13123843 bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 13123843 bus:AbridgedAccounts 2023-02-01 2024-01-31 13123843 bus:OrdinaryShareClass1 2024-01-31 13123843 bus:OrdinaryShareClass1 2023-01-31 13123843 bus:OrdinaryShareClass2 2024-01-31 13123843 bus:OrdinaryShareClass2 2023-01-31 13123843 bus:AllOrdinaryShares 2024-01-31 13123843 bus:AllOrdinaryShares 2023-01-31
COMPANY REGISTRATION NUMBER: 13123843
BIO 5 Limited
Filleted Unaudited Abridged Financial Statements
31 January 2024
BIO 5 Limited
Abridged Statement of Financial Position
31 January 2024
2024
2023
Note
£
£
Current assets
Debtors
52,557
52,557
Creditors: amounts falling due within one year
195,707
195,707
---------
---------
Net current liabilities
143,150
143,150
---------
---------
Total assets less current liabilities
( 143,150)
( 143,150)
---------
---------
Net liabilities
( 143,150)
( 143,150)
---------
---------
Capital and reserves
Called up share capital
4
80
80
Profit and loss account
( 143,230)
( 143,230)
---------
---------
Shareholders deficit
( 143,150)
( 143,150)
---------
---------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the year ending 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.
These abridged financial statements were approved by the board of directors and authorised for issue on 29 January 2025 , and are signed on behalf of the board by:
A D Wheatley
Director
Company registration number: 13123843
BIO 5 Limited
Notes to the Abridged Financial Statements
Year ended 31 January 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 90 Hallam Grange Crescent, Sheffield, S10 4BD.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement
The company is dormant as defined by section 1169 of the Companies Act 2006. The company incurred no significant transactions during the current year or prior year.
4. Called up share capital
Issued, called up and fully paid
2024
2023
No.
£
No.
£
Ordinary A shares of £ 1 each
40
40
40
40
Ordinary B shares of £ 1 each
40
40
40
40
----
----
----
----
80
80
80
80
----
----
----
----
5. Directors' advances, credits and guarantees
At the balance sheet date £2,556 was owed by the directors. This amount is included within other debtors.